Table.
Antimicrobial (189 isolates) | Resistance(%) |
Resistance to ≥ 1 antimicrobials | 65.6 |
Metronidazole | 33.3 |
Clarithromycin | 30.0 |
Levofloxacin | 29.6 |
Amoxicillin | 1.1 |
Rifabutin | 0.5 |
Tetracycline | 0.5 |
Co-resistance patterns (124 isolates resistant to ≥ 1 antimicrobials) | |
Clarithromycin-Metronidazole-Levofloxacin | 9.7 |
Metronidazole-Levofloxacin | 8.1 |
Clarithromycin - Metronidazole | 7.3 |
Clarithromycin -Levofloxacin | 7.3 |
Clarithromycin- Levofloxacin-Tetracycline | 0.8 |
Metronidazole-Levofloxacin-Amoxicillin | 0.8 |
| |
Treatment regimen* (Total [%]) | Eradication Success (%) |
All treatment regimens (187 [100]) | 75.4 |
Quadruple regimens | |
PPI-Tetracycline-Metronidazole-Bismuth (79 [42.2]) | 89.9 |
PPI-Doxycycline-Metronidazole-Bismuth (18 [14.1]) | 83.3 |
PPI-Clarithromycin- Amoxicillin-Metronidazole (4 [3.1]) | 75.0 |
Triple regimens | |
PPI-Clarithromycin- Amoxicillin (62 [48.4]) | 58.1 |
PPI-Clarithromycin- Metronidazole (18 [14.1]) | 61.1 |
PPI-Amoxicillin-Metronidazole (4 [3.1]) | 100 |
PPI-Rifabutin-Amoxicillin (2 [1.6]) | 50.0 |
187 isolates with data on treatment regimen and eradication test
PPI: proton pump inhibitor